ACURA PHARMACEUTICALS, INCACUR
| Dec 31,
2011 | Dec 31,
2013 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 |
|---|
| Cash | - | - | - | - | - | - | 0 | 1 | 0 | 0 |
|---|
| Royalty receivable | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Collaboration Revenue Receivable | - | - | - | - | 0 | - | - | 0 | 0 | 0 |
|---|
| License fees receivable from related party | - | - | - | - | - | - | - | - | 0 | 0 |
|---|
| Prepaid expenses and other current assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Total current assets | 36 | 27 | 13 | 14 | 6 | 3 | 0 | 1 | 1 | 0 |
|---|
| Finance lease right of use | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Property, plant and equipment, net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
|---|
| Intangible asset, net | - | - | 2 | 2 | 1 | 1 | 1 | 1 | 0 | - |
|---|
| Total assets | 37 | 29 | 16 | 17 | 8 | 5 | 2 | 3 | 2 | 1 |
|---|
| Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
|---|
| Accrued expenses | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
|---|
| Finance lease liability - current | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Short-term Debt | - | - | - | - | - | - | - | - | 0 | - |
|---|
| Other current liabilities | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Accrued interest to related party | - | - | - | - | - | - | - | - | 1 | - |
|---|
| Long-term Debt, Current Maturities, Total | - | - | 2 | 2 | 2 | 3 | - | - | 6 | - |
|---|
| Total current liabilities | 1 | 1 | 3 | 3 | 3 | 5 | 1 | 1 | 8 | 1 |
|---|
| Finance lease liability - noncurrent | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Loans under CARES Act - noncurrent | - | - | - | - | - | - | - | - | 0 | - |
|---|
| Promissory note to related party | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Total liabilities | - | 11 | 11 | 9 | 7 | 5 | 6 | 7 | 8 | 1 |
|---|
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
|---|
| Additional paid-in capital | 362 | 367 | 367 | 375 | 376 | 380 | 380 | 383 | 383 | 390 |
|---|
| Accumulated deficit | -326 | -349 | -362 | -367 | -375 | -380 | -384 | -388 | -389 | -390 |
|---|
| Total stockholders' equity (deficit) | 37 | 18 | 5 | 8 | 1 | -0 | -4 | -5 | -6 | 0 |
|---|
| Total liabilities and stockholders' equity (deficit) | 37 | 29 | 16 | 17 | 8 | 5 | 2 | 3 | 2 | 1 |
|---|